Sai Life Sciences Ltd reports Q2 FY27 consolidated revenue of ₹659 crore, up 23% YoY
- EBITDA rose 20% to ₹187 crore; margin was 28%, versus 29% in Q2 FY26.
- Net profit increased 17% to ₹98 crore.
- The company issued an investor presentation on unaudited Q2 and H1 FY27 results ahead of its 11:00 a.m. IST earnings call on 6 November.